No Data
Abterra^ Medical (301097.SZ): Plans to change the use of raised funds.
On December 27, 2023, Abterra^ Medical (301097.SZ) announced that, 1. The "Comprehensive R&D Center Construction Project", originally implemented by its subsidiary Ningbo Tairuisi Technology Co., Ltd., cannot be completed and put into use in the short term due to policy adjustments and other reasons at the implementation location. In order to further improve the efficiency of fundraising and safeguard the interests of the listed company and its Shareholders, the company intends not to implement the "Comprehensive R&D Center Construction Project" and plans to allocate all remaining raised funds to the "Thailand Production Base Construction Project"; 2. The company intends to allocate all remaining excess fundraising funds to the "Thailand Production Base Construction Project".
Abterra^ Medical (301097.SZ): New product disposable external short tubes for peritoneal Hemodialysis has obtained the product registration certificate.
On December 16, Gelonghui announced that Abterra^ Medical (301097.SZ) has recently received the "Medical Instruments Registration Certificate" issued by the Zhejiang Provincial Pharmaceutical Administration. The product is named disposable peritoneal Hemodialysis external connector short tube, used for sterile connection and separation with the peritoneal Hemodialysis patient's end pipeline (or Titanium connector) and the peritoneal Hemodialysis fluid end pipeline.
Ningbo Tianyi Medical Appliance Co., Ltd. (SZSE:301097) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Abterra^ Medical (301097.SZ): Cumulatively repurchased 2.42% of shares
Abterra^ Medical (301097.SZ) announced that as of October 31, 2024, the company has repurchased a total of 1,427,400 shares of the company through the Shenzhen Stock Exchange stock trading system by means of centralized bidding trading, accounting for 2.42% of the company's current total share capital. The highest fill price was 42.80 yuan/share, the lowest fill price was 32.71 yuan/share, and the total fill amount was RMB 57,641,335.95 (excluding stamp duty, transaction commissions and other trading expenses). This repurchase is in compliance with relevant laws and regulations as well as the company's established repurchase plan.
Abterra^ medical (301097.SZ) signed a distribution contract with PMG, with the first year contract amount estimated to be 40 million US dollars.
格隆汇November 4th | abterra^ Medical (301097.SZ) announced that on October 31, 2024, the company signed a "DISTRIBUTION AGREEMENT" with ProCure Medical GmbH (hereinafter referred to as "PMG" or "Buyer"). According to the contract, the contract symbol is blood dialysis tubing, with a duration of 5 years, and the estimated amount for the first year of the contract is 40 million US dollars. Due to fluctuations in raw material prices each year, the two parties may agree to modify the conditions upon mutual agreement.
Tianyi Healthcare: Report for the third quarter of 2024
Should Weakness in Ningbo Tianyi Medical Appliance Co., Ltd.'s (SZSE:301097) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
